Gender-Affirming Hormone Therapy and Depressive Symptoms Among Transgender Adults
In this longitudinal observational cohort study, GAHT was associated with lower rates of moderate-to-severe depressive symptoms, highlighting the importance of gender-affirming primary care models for TGD patients.
Authors
- Asa Radix (ORCID: https://orcid.org/0000-0001-9611-4181)
- Madeline B. Deutsch (ORCID: https://orcid.org/0000-0003-3456-9388)
- David R. Pletta (ORCID: https://orcid.org/0000-0003-0363-153X)
- Jaclyn M. W. Hughto (ORCID: https://orcid.org/0000-0003-4722-8179)
- Jennifer Potter (ORCID: https://orcid.org/0000-0002-6221-8895)
- Sari L. Reisner (ORCID: https://orcid.org/0000-0001-7868-4746)
- Alexander B. Harris (ORCID: https://orcid.org/0000-0002-9991-1482)
- Alex S. Keuroghlian (ORCID: https://orcid.org/0000-0002-6624-8354)
- Kenneth H. Mayer
Institutions
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
- University of California, San Francisco (US)
- Brown University (US)
- University of Michigan (US)
- Massachusetts General Hospital (US)
- Community Health Center (US)
- Fenway Health (US)
- Columbia University (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-03-17
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.0955
- Citations
- 12
- Primary Topic
- LGBTQ Health, Identity, and Policy
- Type
- article
- Field-Weighted Citation Impact
- 29.26